We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Recommendations for Antiviral Drug Development
FDA Offers Recommendations for Antiviral Drug Development
May 27, 2005
Pharmaceutical firms developing antiviral drugs should conduct nonclinical studies of the product candidates before initiating Phase I clinical trials, according to an FDA draft guidance.